Illumina beats estimates for the eighth straight quarter

Mon Oct 21, 2013 4:15pm EDT

Oct 21 (Reuters) - Gene sequencing products maker Illumina Inc beat analysts' estimates for the eighth straight quarter on strong sales.

Third-quarter net income rose to $31.4 million, or 22 cents per share, from $29.7 million, or 22 cents per share, a year earlier.

Total revenue jumped 25 percent to $357 million.

Analysts on average had expected a profit of 40 cents per share, according to Thomson Reuters I/B/E/S.